These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25472733)

  • 1. 'It will harm business and increase illicit trade': an evaluation of the relevance, quality and transparency of evidence submitted by transnational tobacco companies to the UK consultation on standardised packaging 2012.
    Evans-Reeves KA; Hatchard JL; Gilmore AB
    Tob Control; 2015 Jun; 24(e2):e168-77. PubMed ID: 25472733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical evaluation of the volume, relevance and quality of evidence submitted by the tobacco industry to oppose standardised packaging of tobacco products.
    Hatchard JL; Fooks GJ; Evans-Reeves KA; Ulucanlar S; Gilmore AB
    BMJ Open; 2014 Feb; 4(2):e003757. PubMed ID: 24523419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardised tobacco packaging: a health policy case study of corporate conflict expansion and adaptation.
    Hatchard JL; Fooks GJ; Gilmore AB
    BMJ Open; 2016 Oct; 6(10):e012634. PubMed ID: 27855104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Representation and misrepresentation of scientific evidence in contemporary tobacco regulation: a review of tobacco industry submissions to the UK Government consultation on standardised packaging.
    Ulucanlar S; Fooks GJ; Hatchard JL; Gilmore AB
    PLoS Med; 2014 Mar; 11(3):e1001629. PubMed ID: 24667150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco industry manipulation of data on and press coverage of the illicit tobacco trade in the UK.
    Rowell A; Evans-Reeves K; Gilmore AB
    Tob Control; 2014 May; 23(e1):e35-43. PubMed ID: 24614041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can't see the woods for the trees: exploring the range and connection of tobacco industry argumentation in the 2012 UK standardised packaging consultation.
    Lie JLY; Fooks G; de Vries NK; Heijndijk SM; Willemsen MC
    Tob Control; 2018 Jul; 27(4):448-454. PubMed ID: 28743794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.
    Crosbie E; Bialous S; Glantz SA
    Tob Control; 2019 Dec; 28(e2):e110-e118. PubMed ID: 30659106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the European Union's illicit trade agreements with the four major Transnational Tobacco Companies.
    Joossens L; Gilmore AB; Stoklosa M; Ross H
    Tob Control; 2016 May; 25(3):254-60. PubMed ID: 26022741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illicit tobacco trade is 'booming': UK newspaper coverage of data funded by transnational tobacco companies.
    Evans-Reeves K; Hatchard J; Rowell A; Gilmore AB
    Tob Control; 2020 Dec; 29(e1):e78-e86. PubMed ID: 32300025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in tobacco excise policy in Bulgaria: the role of tobacco industry lobbying and smuggling.
    Skafida V; Silver KE; Rechel BP; Gilmore AB
    Tob Control; 2014 May; 23(e1):e75-84. PubMed ID: 23143869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From transit hub to major supplier of illicit cigarettes to Argentina and Brazil: the changing role of domestic production and transnational tobacco companies in Paraguay between 1960 and 2003.
    Iglesias RM; Gomis B; Carrillo Botero N; Shepherd P; Lee K
    Global Health; 2018 Nov; 14(1):111. PubMed ID: 30454015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of submissions to the EU's public consultation on tobacco traceability and security features.
    Gallagher AWA; Evans-Reeves K; Joshi A; Hatchard J; Gilmore AB
    Tob Control; 2021 Nov; 30(e1):e4-e9. PubMed ID: 33023937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "We think globally": the rise of Paraguay's Tabacalera del Este as a threat to global tobacco control.
    Gomis B; Lee K; Carrillo Botero N; Shepherd P; Iglesias RM
    Global Health; 2018 Nov; 14(1):110. PubMed ID: 30454045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creating demand for foreign brands in a 'home run' market: tobacco company tactics in South Korea following market liberalisation.
    Lee S; Lee K; Holden C
    Tob Control; 2014 May; 23(3):e8. PubMed ID: 23152099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-level, multi-jurisdictional strategy: Transnational tobacco companies' attempts to obstruct tobacco packaging restrictions.
    Hawkins B; Holden C; Mackinder S
    Glob Public Health; 2019 Apr; 14(4):570-583. PubMed ID: 29521160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking and tracing the tobacco industry: potential tobacco industry influence over the EU's system for tobacco traceability and security features.
    Gallagher AWA; Gilmore AB; Eads M
    Tob Control; 2020 Dec; 29(e1):e56-e62. PubMed ID: 31543502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waterpipe industry products and marketing strategies: analysis of an industry trade exhibition.
    Jawad M; Nakkash RT; Hawkins B; Akl EA
    Tob Control; 2015 Dec; 24(e4):e275-9. PubMed ID: 26149455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tobacco industry's challenges to standardised packaging: A comparative analysis of issue framing in public relations campaigns in four countries.
    MacKenzie R; Mathers A; Hawkins B; Eckhardt J; Smith J
    Health Policy; 2018 Sep; 122(9):1001-1011. PubMed ID: 30139670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials.
    Gilmore AB
    Tob Control; 2012 Mar; 21(2):119-26. PubMed ID: 22345234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials.
    Peeters S; Gilmore AB
    PLoS Med; 2013; 10(9):e1001506. PubMed ID: 24058299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.